Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 Generation Test with Nutropin in Short Children
NCT01438801Phase 4Withdrawn
- Sponsor
- Ipsen
- Start
- May 2013
- Primary completion
- May 2013
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Idiopathic Short Stature (ISS), sponsored by Ipsen. Primary endpoint: Peak serum IGF-1 level with GH change from baseline at 2 weeks. Planned start May 2013; status: withdrawn.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT01438801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438801.